BioPortUSA News and Event Updates

MAP BioPharma is a U.K. based life science consultancy that works with several partners who share their vision to accelerate patient access and support Pharmaceutical and MedTech companies in reaching patients sooner with their medicines, devices, and diagnostics. Christian Hill, CEO & Co-Founder of MAP BioPharma says that “BioPortUSA facilitates entry for overseas-life sciences companies into the United States so are a natural fit and addition to MAP’s network and we look forward to working with them to support our clients”. MAP BioPharm’s extensive knowledge of the European healthcare environment provides strategic guidance for successful European Market entry. Operating in a diverse market requires careful consideration. Their team will guide you through the necessary steps and provide a blueprint to ensure that you have covered all the requirements for the European Market. Christian has built a solid company, with an incredible network that will no doubt benefit our clients who are looking to go overseas. We in turn look forward to supporting MAPBioPharma clients who are looking to gain entry into the USA’’ says CEO & Founder Mark Lesselroth. [...]

European Medical Market Access Network (EUMMAN) has invited BioPortUSA to present a webinar on market entry USA to their clients on Monday, June 8th, 2020. Mark Lesselroth, CEO of BioPort will talk about what it takes to be successful in the U.S. Healthcare market and what steps one should take before considering entering the market.[...]

Teicos Pharma (www.teicospharma.com) is a Finish based Pharmaceutical Start-Up whose business is the production and sales of a new class of inhalable API (active pharmaceutical ingredient) powders for dry powder Inhalers (DPI). [...]

BioPortUSA is excited to announce the addition of Dr. Karsten Risch to our Board of Advisors. Dr. Risch brings a unique skill set as Chief Medical officer for Evoke, a global life science marketing communications firm. [...]